FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penz, S.
Right arrow Articles by Siess, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penz, S.
Right arrow Articles by Siess, W.
(The FASEB Journal. 2005;19:898-909.)
© 2005 FASEB

Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI

Sandra Penz*, Armin J. Reininger{dagger}, Richard Brandl{ddagger}, Pankaj Goyal*, Tamer Rabie§, Isabell Bernlochner*, Enno Rother*, Christine Goetz||, Bernd Engelmann||, Peter A. Smethurst{dagger}{dagger}, Willem H. Ouwehand{ddagger}{ddagger}, Richard Farndale{dagger}{dagger}, Bernhard Nieswandt§ and Wolfgang Siess*,1

* Institute for Prevention of Cardiovascular Diseases,
{dagger} Department of Transfusion Medicine and Hemostaseology, University of Munich, Munich;
{ddagger} Department of Vascular Surgery, Klinikum Munich-Schwabing, Munich;
§ Rudolf-Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg;
|| Vascular Biology and Hemostasis, Institute of Clinical Chemistry, University of Munich, Munich, Germany; and
{dagger}{dagger} Department of Biochemistry and
{ddagger}{ddagger} Department of Hematology, University of Cambridge, Cambridge, UK

1Correspondence: Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Klinikum Innenstadt, Universität München, Pettenkoferstr. 9, D 80336 München, Germany. E-mail: wsiess{at}med.uni-muenchen.de

Lipid-rich atherosclerotic plaques are vulnerable, and their rupture can cause the formation of a platelet- and fibrin-rich thrombus leading to myocardial infarction and ischemic stroke. Although the role of plaque-based tissue factor as stimulator of blood coagulation has been recognized, it is not known whether plaques can cause thrombus formation through direct activation of platelets. We isolated lipid-rich atheromatous plaques from 60 patients with carotid stenosis and identified morphologically diverse collagen type I- and type III-positive structures in the plaques that directly stimulated adhesion, dense granule secretion, and aggregation of platelets in buffer, plasma, and blood. This material also elicited platelet-monocyte aggregation and platelet-dependent blood coagulation. Plaques exposed to flowing blood at arterial wall shear rate induced platelets to adhere to and spread on the collagenous structures, triggering subsequent thrombus formation. Plaque-induced platelet thrombus formation was observed in fully anticoagulated blood (i.e., in the absence of tissue factor-mediated coagulation). Mice platelets lacking glycoprotein VI (GPVI) were unable to adhere to atheromatous plaque or form thrombi. Human platelet thrombus formation onto plaques in flowing blood was completely blocked by GPVI inhibition with the antibody 10B12 but not affected by integrin {alpha}2ß1 inhibition with 6F1 mAb. Moreover, the initial platelet response, shape change, induced by plaque was blocked by GPVI inhibition but not with {alpha}2ß1 antagonists (6F1 mAb or GFOGER-GPP peptide). Pretreatment of plaques with collagenase or anti-collagen type I and anti-collagen type III antibodies abolished plaque-induced platelet activation. Our results indicate that morphologically diverse collagen type I- and collagen type III-containing structures in lipid-rich atherosclerotic plaques stimulate thrombus formation by activating platelet GPVI. This platelet collagen receptor, essential for plaque-induced thrombus formation, presents a promising new anti-thrombotic target for the prevention of ischemic cardiovascular diseases.—Penz, S., Reininger, A. J., Brandl, R., Goyal, P., Rabie, T., Bernlochner, I., Rother, E., Goetz, C., Engelmann, B., Smethurst, P. A., Ouwehand, W. H., Farndale, R., Nieswandt, B., Siess, W. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.


Key Words: atherosclerotic plaques • ischemic stroke • thrombogenicity • arterial thrombus




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Consoli, E. Martelli, M. D'Adamo, R. Menghini, D. Arcelli, O. Porzio, A. Pandolfi, G. R. Pistolese, A. Consoli, R. Lauro, et al.
Insulin Resistance Affects Gene Expression in Endothelium
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): e7 - e9.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Calvo, F. Tokumasu, O. Marinotti, J.-L. Villeval, J. M. C. Ribeiro, and I. M. B. Francischetti
Aegyptin, a Novel Mosquito Salivary Gland Protein, Specifically Binds to Collagen and Prevents Its Interaction with Platelet Glycoprotein VI, Integrin {alpha}2beta1, and von Willebrand Factor
J. Biol. Chem., September 14, 2007; 282(37): 26928 - 26938.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Rabie, D. Varga-Szabo, M. Bender, R. Pozgaj, F. Lanza, T. Saito, S. P. Watson, and B. Nieswandt
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Blood, July 15, 2007; 110(2): 529 - 535.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. M. Ruggeri and G. L. Mendolicchio
Adhesion Mechanisms in Platelet Function
Circ. Res., June 22, 2007; 100(12): 1673 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Grothusen, S. Umbreen, I. Konrad, K. Stellos, C. Schulz, B. Schmidt, E. Kremmer, O. Teebken, S. Massberg, M. Luchtefeld, et al.
EXP3179 Inhibits Collagen-Dependent Platelet Activation via Glycoprotein Receptor-VI Independent of AT1-Receptor Antagonism: Potential Impact on Atherothrombosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1184 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. J.H. Sachs and B. Nieswandt
In Vivo Thrombus Formation in Murine Models
Circ. Res., April 13, 2007; 100(7): 979 - 991.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Gross, P. Tilly, D. Hentsch, J.-L. Vonesch, and J.-E. Fabre
Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors
J. Exp. Med., February 19, 2007; 204(2): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. N. O'Connor, P. A. Smethurst, L. W. Davies, L. Joutsi-Korhonen, D. J. Onley, A. B. Herr, R. W. Farndale, and W. H. Ouwehand
Selective Blockade of Glycoprotein VI Clustering on Collagen Helices
J. Biol. Chem., November 3, 2006; 281(44): 33505 - 33510.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. Bigalke, S. Lindemann, R. Ehlers, P. Seizer, K. Daub, H. Langer, T. Schonberger, E. Kremmer, D. Siegel-Axel, A. E. May, et al.
Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome
Eur. Heart J., September 2, 2006; 27(18): 2165 - 2169.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Kahn
GPVI: no magic bullet for thrombosis
Blood, June 1, 2006; 107(11): 4199 - 4199.
[Full Text] [PDF]


Home page
BloodHome page
A. J. Reininger, H. F. G. Heijnen, H. Schumann, H. M. Specht, W. Schramm, and Z. M. Ruggeri
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress
Blood, May 1, 2006; 107(9): 3537 - 3545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Federation of American Societies for Experimental Biology.